文献速递头颈与中枢神经肿瘤

头颈癌治疗后强化影像监测的经济学评价

The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
PubMed 文献 · Eur J Cancer · 2018-03-20

本研究构建决策分析马尔可夫模型,比较头颈癌根治性治疗后5年内强化影像监测(最大化方案)与症状驱动监测(最小化方案)的成本效果。基于意大利某大区医疗系统视角,强化方案每例患者增加0.10 QALY(0.15 LYG)和1903欧元成本,增量成本效果比为19951欧元/QALY(13123欧元/LYG)。概率敏感性分析中72%结果低于40000欧元/QALY阈值(55%低于25000欧元)。

要点

  • 强化影像监测较症状驱动监测每例增加0.10 QALY,增量成本19951欧元/QALY。
  • 概率敏感性分析中72%结果低于40000欧元/QALY阈值。
  • 结论需在实证研究或真实世界环境中进一步验证。

核心结论

  • 头颈癌治疗后定期强化影像监测相比症状驱动监测可能具有成本效果。

研究设计与样本

  • 采用决策分析马尔可夫模型,评估两种随访方案在终生视野下的成本效用。
  • 两种干预在5年内影像检查(MRI、CT、PET)次数不同。
  • 成本和效果参数来自已发表和未发表文献及专家意见。
  • 成本分析从意大利某大区医疗系统视角进行。

主要发现

  • 基础分析中,强化影像方案较最小化方案每例患者增加0.10 QALY(0.15 LYG)。
  • 强化方案每例患者成本增加1903欧元。
  • 增量成本效果比为19951欧元/QALY(13123欧元/LYG)。
  • 概率敏感性分析中,72%的结果低于40000欧元/QALY阈值,55%低于25000欧元/QALY。

关键数值与推荐

  • 成本效果阈值设定为每QALY 25000-40000欧元。
  • 强化方案增量成本效果比19951欧元/QALY,低于40000欧元阈值。

临床怎么用

  • 对于头颈癌根治性治疗后患者,可考虑在5年内安排定期强化影像监测。
  • 决策时需结合当地医疗系统成本阈值和患者具体情况。

局限性

  • 结果需在实证研究或真实世界环境中进一步验证。
  • 临床和效用参数部分来自专家意见,存在不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is uncertainty around the optimal surveillance of head and neck cancer patients after the primary curative treatment. This study aims at assessing the cost-effectiveness of a post-treatment programme of frequent radiological assessments (maximal approach) compared with a symptom-driven surveillance (minimal approach). MATERIALS AND METHODS: A decision-analytic Markov model is developed to assess the cost utility of two alternative follow-up programmes with a lifetime horizon. The two interventions differ in the number of radiological assessments (i.e. magnetic resonance imaging, computed tomography and positron-emission tomography) performed over a 5-year period. Clinical and utility parameters are derived from published and unpublished literature and expert opinion. The cost analysis is conducted from the perspective of a major Italian region's health care system. Cost-effectiveness results are expressed as incremental cost per life year gained (LYG) and per quality-adjusted life year (QALY) and checked against a cost-effectiveness threshold of €25,000-40,000 per QALY. One-way, two-way and probabilistic sensitivity analyses are carried out. RESULTS: In the base-case analysis, an intensive programme of radiological investigations leads to 0.10 additional QALYs (0.15 LYG) and an increase in costs of €1903 per patient compared with those of a minimal option, resulting in an incremental cost of €19,951/QALY gained (€13,123/LYG). In probabilistic sensitivity analysis, 72% of the results lie below the €40,000 threshold (55% below €25,000). CONCLUSIONS: An intensive post-treatment follow-up with scheduled radiological assessments over time might be cost-effective compared with symptom-driven surveillance in head and neck cancer patients. Further research is needed to check these results in empirical studies or real-world settings.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Meregaglia M, Cairns J, Licitra L, et al. The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation. Eur J Cancer. 2018. PMID: 29477796. doi:10.1016/j.ejca.2018.01.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。